Company: GEHC
Filing Date: 2025-04-30
Form Type: 10-Q
Source: 0001932393-25-000014
Chunk: 6

Company: GE HealthCare Technologies Inc.
Filing Date: 2025-04-30
Form: 10-Q
Item: Item 8
Chunk 6
---
 credit losses(6)(5)Total long-term receivables – net$161 $142 Long-term receivables are recognized within All other non-current assets in the Condensed Consolidated Statements of Financial Position.

NOTE 5. FINANCING RECEIVABLES

Current financing receivables and non-current financing receivables are recognized within All other current assets and All other non-current assets, respectively, in the Condensed Consolidated Statements of Financial Position.As ofMarch 31, 2025December 31, 2024Loans receivable, at amortized cost$23 $23 Investment in finance leases, net of deferred income69 69 Allowance for credit losses(3)(2)Current financing receivables – net$90 $90 Loans receivable, at amortized cost$35 $35 Investment in finance leases, net of deferred income155 152 Allowance for credit losses(4)(4)Non-current financing receivables – net$186 $183 As of March 31, 2025, 3%, 3%, and 3% of financing receivables were over 30 days past due, over 90 days past due, and on nonaccrual, respectively, with the majority of nonaccrual financing receivables secured by collateral. As of December 31, 2024, 4%, 4%, and 3% of financing receivables were over 30 days past due, over 90 days past due, and on nonaccrual, respectively, with the majority of nonaccrual financing receivables secured by collateral.

NOTE 6. LEASES

Operating lease liabilities recognized within All other current liabilities and All other non-current liabilities in the Condensed Consolidated Statements of Financial Position were $386 million and $385 million as of March 31, 2025 and December 31, 2024, respectively. The total lease expense related to our operating lease portfolio was $62 million and $60 million for the three months ended March 31, 2025 and 2024, respectively.

NOTE 7. ACQUISITIONS, GOODWILL, AND OTHER INTANGIBLE ASSETS

ACQUISITIONS.Nihon Medi-PhysicsOn March 31, 2025, the Company acquired the remaining 50% interest in Nihon Medi-Physics Co., Ltd (“NMP”) from